Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T22:47:51.602Z.
Calculation as of: 2026-10-06T22:47:51.602Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 23d17170dcd90d56222e16e6e1c46ca5d6e49f0f5e08d353dc7d5f06f7b1586d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$9.63B
Free Cash Flow Yield
2.68%
TTM Avg
2.45%
3Y Avg
2.48%
5Y Avg
2.48%
Market Cap
$9.66B
Free Cash Flow Yield
5.58%
TTM Avg
4.93%
3Y Avg
5.16%
5Y Avg
5.30%
Market Cap
$9.87B
Free Cash Flow Yield
1.12%
TTM Avg
1.28%
3Y Avg
1.32%
5Y Avg
0.94%
Market Cap
$9.93B
Free Cash Flow Yield
3.56%
TTM Avg
4.30%
3Y Avg
3.40%
5Y Avg
2.87%
Market Cap
$10.03B
Free Cash Flow Yield
4.18%
TTM Avg
3.38%
3Y Avg
3.13%
5Y Avg
3.61%
Market Cap
$9.21B
Free Cash Flow Yield
1.02%
TTM Avg
0.80%
3Y Avg
1.68%
5Y Avg
1.69%
Market Cap
$10.13B
Free Cash Flow Yield
N/A
TTM Avg
3.41%
3Y Avg
2.72%
5Y Avg
2.30%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.63B | N/A | N/A | N/A | N/A |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | 2.68% | 2.45% | 2.48% | 2.48% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 5.58% | 4.93% | 5.16% | 5.30% |
| Repligen Corporation (RGEN)vs › | $9.87B | 1.12% | 1.28% | 1.32% | 0.94% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 3.56% | 4.30% | 3.40% | 2.87% |
| Insulet Corp. (PODD)vs › | $9.33B | 3.20% | 2.73% | 1.80% | 1.80% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 4.18% | 3.38% | 3.13% | 3.61% |
| Bruker Corporation (BRKR)vs › | $9.21B | 1.02% | 0.80% | 1.68% | 1.69% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | N/A | 3.41% | 2.72% | 2.30% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
